Soft Tissue Graft Versus Acellular Dermal Matrix in Preservation of Buccal Plate of Bone

NCT ID: NCT06229561

Last Updated: 2024-01-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-18

Study Completion Date

2023-05-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparative study between 2 groups to assess the feasibility of using Acellular dermal matrix vs Soft tissue Graft after immediate implant placement

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It was conclude that SCTG is the gold standard for soft tissue augmentation up till now, However ADM can be alternative to autogenous soft tissue graft.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Comparative Study

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ADM and SCTG

ADM and SCTG

Group Type EXPERIMENTAL

Acellular Dermal Matrix

Intervention Type COMBINATION_PRODUCT

Feasibility of soft tissue graft after immediate implant placement

Acellular Dermal Matrix and soft tissue graft

12participatent in two groups

Group Type EXPERIMENTAL

Acellular Dermal Matrix

Intervention Type COMBINATION_PRODUCT

Feasibility of soft tissue graft after immediate implant placement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acellular Dermal Matrix

Feasibility of soft tissue graft after immediate implant placement

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Medically free

Exclusion Criteria

Heavy smoking
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Faculty of Dental Medicine for Girls

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nehal Mohamed Ibrahim Abbas

Principle investor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Azhar Journal

Role: PRINCIPAL_INVESTIGATOR

No affliction

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Azhar University

Nāşir, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Elaskary A, Abdelrahman H, Elfahl B, Elsabagh H, El-Kimary G, Ghallab NA. Immediate Implant Placement in Intact Fresh Extraction Sockets Using Vestibular Socket Therapy Versus Partial Extraction Therapy in the Esthetic Zone: A Randomized Clinical Trial. Int J Oral Maxillofac Implants. 2023 May, Jun;38(3):468-478. doi: 10.11607/jomi.9973.

Reference Type RESULT
PMID: 37279214 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Nmohamed

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.